Insulet gains after hours on Q3 results
November 8, 2012 by MassDevice staff
Investors push Insulet shares up in after-hours trading on news of a nearly 23% sales increase and lower losses.
Insulet (NSDQ:PODD) shares gained after the market's close today after the medical device company reported strong sales growth and lower losses for the 3rd quarter.
Bedford, Mass.-based Insulet reported losses of $12.4 million, or 26¢ per share, on sales of $54.8 million during the 3 months ended Sept. 30, reducing losses by some 8.4%.
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
Navigation
NEWS
European regulators green-light valve-in-valve procedures
Medical device giant Medtronic says its European CE Mark is the 1st ever regulatory approval for...
Biosense Webster launches Afib ablation study for nMARQ system
Johnson & Johnson subsidiary Biosense Webster enrolls its 1st patient in the reMARQable clinical...
GPO: Healthcare collaborative teams up within the Premier network
Four health systems create a collaborative group as part of the Premier network
Agea Medical has its sights on an $8 million offering
Agea Medical is $2 million shy of its $8 million funding round goal
FDA panel to consider down-classifying blade-form dental implants
The FDA's Dental Products Panel is scheduled to deliberate on whether the agency should lower blade-...
